Taking the BAD out of adrenergic stimulation

Journal of Molecular and Cellular Cardiology

Volumn 34, Issue 7, 2002, Pages 709-712

  Mani, Kartik ^a   Ashton, Anthony W ^a   Kitsis, Richard N ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; BETA 1 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CASPASE 8; CASPASE 9; CYTOCHROME C; DEOXYGLUCOSE; FAS LIGAND; PHENYLEPHRINE; PRAZOSIN; PROPRANOLOL; PROTEIN BAD; PROTEIN BAK; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN SERINE KINASE; TUMOR NECROSIS FACTOR ALPHA;

ADRENERGIC STIMULATION; APOPTOSIS; CELL SURVIVAL; EDITORIAL; ENZYME ACTIVATION; ENZYME RELEASE; HEART MITOCHONDRION; HEART MUSCLE CELL; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM;

EID: 0036660957     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.2002.2042     Document Type: Editorial

References (25)

1. Rona G, Chappel C, Balazs T, Gaudry R. An infarct-like myocardial lesion and other toxic manifestations produced by isoproterenol in the rat. Am Med Assoc Arch Pathol 1959; 67: 443-455.
2. Shizukuda Y, Buttrick PM, Geenen DL, Borczuk AC, Kitsis RN, Sonnenblick. EH. β-adrenergic stimulation causes cardiocyte apoptosis: influence of tachycardia and hypertrophy. Am J Physiol 1998: 275: H961-H968.
3. Communal C, Singh K, Pimentel DR, Colucci WS. Norepinephrine stimulates apoptosis in adult rat ventricular myocytes by activation of the β-adrenergic pathway. Circulation 1998; 98: 1329-1334.
4. Iwai-Kanai E, Hasegawa K, Araki M, Kakita T, Morimoto T, Sasayama, S. α- and β-adrenergic pathways differentially regulate cell type- specific apoptosis in rat cardiac myocytes. Circulation 1999: 100: 305-311.
5. 2-adrenergic signaling in adult mouse cardiac myocytes. Proc Natl Acad Sci USA 2001; 98: 1607-1612.
6. 2-adrenergic receptor delivers an antiapoptotic signal to cardiac myocytes through G(i)-dependent coupling to phosphatidylinositol 3′-kinase. Circ Res 2000; 87: 1172-1179.
7. Adams JW, Sakata Y, Davis MG, Sah VP, Wang Y, Liggett SB, Chien KR, Brown JH, Dorn GW, 2nd. Enhanced Gaq signaling: a common pathway mediates cardiac hypertrophy and apoptotic heart failure. Proc Natl Acad Sci USA 1998: 95: 10140-10145.
8. 1-adrenergic receptor stimulation. Biochem Biophys Res Commun 2002: 291: 995-1000.
9. 1-adrenoceptors involves inhibition of apoptosis. J Thorac Cardiovasc Surg 1999; 117: 980-986.
10. Messerli FH. Implications of discontinuation of doxazosin arm of ALLHAT. Antihypertensive and lipid-lowering treatment to prevent heart attack trial. Lancet 2000; 355: 863-864.
11. Thornberry NA, Lazebnik Y. Caspases: enemies within. Science 1998; 281: 1312-1316.
12. Green DR, Reed JC. Mitochondria and apoptosis. Science 1998: 281: 1309-1312.
13. Cheng EH, Wei MC, Weiler S, Flavell RA, Mak TW, Lindsten T, Korsmeyer SJ. Bcl-2, Bcl-xL sequester BH3 domain-only molecules preventing Bax- and Bak-mediated mitochondrial apoptosis. Mol Cell 2001; 8: 705-711.
14. Yang E, Zha J, Jockel J, Boise LH, Thompson CB, Korsmeyer, SJ. Bad, a heterodimeric partner for Bcl-xL and Bcl-2, displaces Bax and promotes cell death. Cell 1995: 80: 285-291.
15. Kelekar A, Chang BS, Harlan JE, Fesik SW, Thompson CB. Bad is a BH3 domain-containing protein that forms an inactivating dimer with Bcl-xL. Mol Cell Biol 1997; 17: 7040-7046.
16. Zha J, Harada H, Yang E, Jockel J, Korsmeyer SJ. Serine phosphorylation of death agonist Bad in response to survival factor results in binding to 14-3-3 not Bcl-xL. Cell 1996: 87: 619-628.
17. Lizcano JM, Morrice N, Cohen P. Regulation of Bad by cAMP-dependent protein kinase is mediated via phosphorylation of a novel site. Ser155. Biochem J 2000: 349: 547-557.
18. Tan Y, Demeter MR, Ruan H, Comb MJ. Bad Ser-155 phosphorylation regulates Bad/Bcl-xL interaction and cell survival. J Biol Chem 2000: 275: 25865-25869.
19. Dramsi S, Scheid MP, Maiti A, Hojabrpour P, Chen X, Schubert K, Goodlett DR, Aebersold R, Duronio V. Identification of a novel phosphorylation site, Ser170, as a regulator of Bad pro-apoptotic activity. J Biol Chem 2002: 277: 6399-6405.
20. Datta SR, Katsov A, Hu L, Petros A, Fesik SW, Yaffe MB, Greenberg ME. 14-3-3 proteins and survival kinases cooperate to inactivate Bad by BH3 domain phosphorylation. Mol Cell 2000: 6: 41-51.
21. Tan Y, Ruan H, Demeter MR, Comb MJ. p90RSK blocks Bad-mediated cell death via a protein kinase C-dependent pathway. J Biol Chem 1999: 274: 34859-34867.
22. Harada H, Becknell B, Wilm M, Mann M, Huang LJ, Taylor SS, Scott JD, Korsmeye, SJ. Phosphorylation and inactivation of Bad by mitochondria-anchored protein kinase A. Mol Cell 1999: 3: 413-422.
23. Harada H, Andersen JS, Mann M, Terada N, Korsmeyer SJ. p70S6 kinase signals cell survival as well as growth, inactivating the pro-apoptotic molecule Bad. Proc Natl Acad Sci USA 2001: 98: 9666-9670.
24. Valks DM, Cook SA, Fong HP, Morrison PR, Clerk A, Sugden PH. Phenylephrine promotes phosphorylation of Bad in cardiac myocytes through ERK 1/2 and PKA. J Mol Cell Cardiol 2002; 34: 749-763 (in this issue).
25. Virdee K, Parone PA, Tolkovsky AM. Phosphorylation of the pro-apoptotic protein Bad on serine 155, a novel site, contributes to cell survival. Curr Biol 2000: 10: 1151-1154.